Comparison of mu opioid agonists in vitro
Hirning, L.D.; Peterson, L.J.; Burks, T.F.
Proceedings of the Western Pharmacology Society 28: 111-113
1985
ISSN/ISBN: 0083-8969 PMID: 2999802 Document Number: 250011
Document emailed within 1 workday
Related Documents
Cserpán, E.; Tryoen-Tóth, P.; Bajenaru, L.; Benyhe, S.; Maderspach, K. 1997: Differential expression of the K-2 opioid receptor protein under the effect of opioid agonists in embryonic chick neurons in vitro Neurobiology 5(2): 233-248Holzgrabe, U.; Nachtsheim, C.; Siener, T.; Drosihn, S.; Brandt, W. 1997: Opioid agonists and antagonists, opioid receptors Die Pharmazie 52(1): 4-22
Sofuoglu, M.; Portoghese, P.S.; Takemori, A.E. 1991: Differential antagonism of delta opioid agonists by naltrindole and its benzofuran analog (NTB) in mice: evidence for delta opioid receptor subtypes Journal of Pharmacology and Experimental Therapeutics 257(2): 676-680
Eglen, R.M.; Whiting, R.L. 1989: Comparison of the positive chronotropic response to 5-hydroxytryptamine with beta-adrenoceptor agonists on the guinea pig atria in vitro Journal of Cardiovascular Pharmacology 13(1): 45-51
Mosberg, H.I.; Heyl, D.L.; Haaseth, R.C.; Omnaas, J.R.; Medzihradsky, F.; Smith, C.B. 1990: Cyclic dermorphin-like tetrapeptides with delta-opioid receptor selectivity. 3. Effect of residue 3 modification on in vitro opioid activity Molecular Pharmacology 38(6): 924-928
Yuan, X.R. 1996: Inhibitory effects of three opioid receptor agonists on synaptic transmission Zhongguo Yao Li Xue Bao 17(3): 278-280
Kotlińska, J.; Langwiński, R. 1990: The lack of effect of opioid agonists and antagonists on some acute effects of ethanol Polish Journal of Pharmacology and Pharmacy 42(2): 129-135
Garaulet, J.V.; Laorden, M.L.; Milanés, M.V. 1994: Cross-tolerance between mu- and kappa-opioid agonists in the guinea pig ileum myenteric plexus Journal of Pharmacology and Experimental Therapeutics 269(3): 993-999
Romualdi, P.; Lesa, G.; Ferri, S. 1990: Chronic exposure to opioid agonists and antagonists affects prodynorphin gene expression Acta Physiologica Hungarica 75 Suppl: 247-248
Hall, E.D.; Wolf, D.L.; McCall, R.B. 1988: Cardiovascular depressant effects of the kappa opioid receptor agonists U50488H and spiradoline mesylate Circulatory Shock 26(4): 409-417
Winger, G.; Skjoldager, P.; Woods, J.H. 1992: Effects of buprenorphine and other opioid agonists and antagonists on alfentanil- and cocaine-reinforced responding in rhesus monkeys Journal of Pharmacology and Experimental Therapeutics 261(1): 311-317
Cabral, A.M.; Varner, K.J.; Kapusta, D.R. 1997: Renal excretory responses produced by central administration of opioid agonists in ketamine and xylazine-anesthetized rats Journal of Pharmacology and Experimental Therapeutics 282(2): 609-616
Hylden, J.L.; Wilcox, G.L. 1983: Pharmacological characterization of substance P-induced nociception in mice: modulation by opioid and noradrenergic agonists at the spinal level Journal of Pharmacology and Experimental Therapeutics 226(2): 398-404
Gulati, K.; Ray, A.; Sharma, K.K. 1992: Effects of acute or chronic opioid agonists and their modulation by diurnal rhythmicity and satiety states on food intake in rats Indian Journal of Experimental Biology 30(3): 185-189
Maslov, L.N.; Mrochek, A.G.; Khaliulin, I.G.; Krylatov, A.V.; Portnichenko, A.G.; Chausskaia, E.; Naryzhnaia, N.V.; Gorbunov, A.S.; Tsibulnikov, S.Iu. 2014: Perspective of use of agonists of adenosine and opioid receptors for prevention of reperfusion damages of heart. Analysis of experimental and clinical data Vestnik Rossiiskoi Akademii Meditsinskikh Nauk 2014(5-6): 5-13
Picker, M.J.; Doty, P.; Negus, S.S.; Mattox, S.R.; Dykstra, L.A. 1990: Discriminative stimulus properties of U50,488 and morphine: effects of training dose on stimulus substitution patterns produced by mu and kappa opioid agonists Journal of Pharmacology and Experimental Therapeutics 254(1): 13-22
Giardina, G.; Clarke, G.D.; Grugni, M.; Sbacchi, M.; Vecchietti, V. 1995: Central and peripheral analgesic agents: chemical strategies for limiting brain penetration in kappa-opioid agonists belonging to different chemical classes Farmaco 50(6): 405-418
Check, M.L.; Check, J.H.; Choel, J.K.; Davies, E.; Kiefer, D. 2004: Effect of antagonists vs agonists on in vitro fertilization outcome Clinical and Experimental Obstetrics and Gynecology 31(4): 257-259
Oudart, N.; Sercombe, R.; Aubineau, P.; Boulu, R.G.; Seylaz, J. 1981: Relaxation by dopaminergic agonists in cerebral and peripheral arteries (in vitro) Archives Internationales de Pharmacodynamie et de Therapie 252(2): 196-209
Pasotti, D.; Marcoli, M.; Mazzone, A. 1988: In vitro effects of morphine and opioid peptides on granulocyte migration Medicina 8(1): 53-55